139 related articles for article (PubMed ID: 16195766)
21. Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification.
Lal P; Salazar PA; Ladanyi M; Chen B
J Mol Diagn; 2003 Aug; 5(3):155-9. PubMed ID: 12876205
[TBL] [Abstract][Full Text] [Related]
22. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.
Allander SV; Illei PB; Chen Y; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS
Am J Pathol; 2002 Nov; 161(5):1587-95. PubMed ID: 12414507
[TBL] [Abstract][Full Text] [Related]
23. HER-2/neu oncogene amplification and chromosome 17 aneusomy in endometrial carcinoma: correlation with oncoprotein expression and conventional pathological parameters.
Cianciulli AM; Guadagni F; Marzano R; Benevolo M; Merola R; Giannarelli D; Marandino F; Vocaturo G; Mariani L; Mottolese M
J Exp Clin Cancer Res; 2003 Jun; 22(2):265-71. PubMed ID: 12866577
[TBL] [Abstract][Full Text] [Related]
24. c-myc oncogene amplification and cytometric DNA ploidy pattern as prognostic factors in musculoskeletal neoplasms.
Barrios C; Castresana JS; Falkmer UG; Rosendahl I; Kreicbergs A
Int J Cancer; 1994 Sep; 58(6):781-6. PubMed ID: 7927868
[TBL] [Abstract][Full Text] [Related]
25. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
[TBL] [Abstract][Full Text] [Related]
26. Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Muraca PJ; Ross JS
J Clin Oncol; 1998 Apr; 16(4):1302-9. PubMed ID: 9552030
[TBL] [Abstract][Full Text] [Related]
27. Molecular alterations of monophasic synovial sarcoma: loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity.
Pazzaglia L; Benassi MS; Ragazzini P; Gamberi G; Ponticelli F; Chiechi A; Hattinger CM; Morandi L; Alberghini M; Zanella L; Picci P; Mercuri M
Histol Histopathol; 2006 Feb; 21(2):187-95. PubMed ID: 16329043
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer.
Mark HF; Feldman D; Das S; Kye H; Mark S; Sun CL; Samy M
Exp Mol Pathol; 1999 Jun; 66(2):170-8. PubMed ID: 10409446
[TBL] [Abstract][Full Text] [Related]
29. Her-2/neu gene amplification in low to moderately expressing breast cancers: possible role of chromosome 17/Her-2/neu polysomy.
Bose S; Mohammed M; Shintaku P; Rao PN
Breast J; 2001; 7(5):337-44. PubMed ID: 11906444
[TBL] [Abstract][Full Text] [Related]
30. Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
Riben MW; Malfetano JH; Nazeer T; Muraca PJ; Ambros RA; Ross JS
Mod Pathol; 1997 Aug; 10(8):823-31. PubMed ID: 9267826
[TBL] [Abstract][Full Text] [Related]
31. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
Lin F; Shen T; Prichard JW
Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
[TBL] [Abstract][Full Text] [Related]
32. The association of HER-2/neu amplification with breast cancer recurrence.
Carr JA; Havstad S; Zarbo RJ; Divine G; Mackowiak P; Velanovich V
Arch Surg; 2000 Dec; 135(12):1469-74. PubMed ID: 11115354
[TBL] [Abstract][Full Text] [Related]
33. Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Walch A; Specht K; Bink K; Zitzelsberger H; Braselmann H; Bauer M; Aubele M; Stein H; Siewert JR; Höfler H; Werner M
Lab Invest; 2001 Jun; 81(6):791-801. PubMed ID: 11406641
[TBL] [Abstract][Full Text] [Related]
34. Dual fluorescence in situ hybridization in detection of HER-2 oncogene amplification in primary hepatocellular carcinoma.
Huang TJ; Huang BJ; Liang QW; Huang CW; Fang Y
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):62-8. PubMed ID: 14969840
[TBL] [Abstract][Full Text] [Related]
35. Expression of MYCN in pediatric synovial sarcoma.
Somers GR; Zielenska M; Abdullah S; Sherman C; Chan S; Thorner PS
Mod Pathol; 2007 Jul; 20(7):734-41. PubMed ID: 17464317
[TBL] [Abstract][Full Text] [Related]
36. Determination of HER-2 status and chromosome 17 polysomy in breast carcinomas comparing HercepTest and PathVysion FISH assay.
Varshney D; Zhou YY; Geller SA; Alsabeh R
Am J Clin Pathol; 2004 Jan; 121(1):70-7. PubMed ID: 14750243
[TBL] [Abstract][Full Text] [Related]
37. c-erbB-2 expression in primary gastric carcinomas and their metastases.
David L; Seruca R; Nesland JM; Soares P; Sansonetty F; Holm R; Børresen AL; Sobrinho-Simões M
Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880
[TBL] [Abstract][Full Text] [Related]
38. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
Kapranos N; Kounelis S; Karantasis H; Kouri E
Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
[TBL] [Abstract][Full Text] [Related]
39. Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin.
da Cunha IW; De Brot L; Carvalho KC; Rocha RM; Fregnani JH; Falzoni R; Ferreira Fde O; Aguiar S; Lopes A; Muto NH; Reis LF; Soares FA; Vassallo J
Ann Surg Oncol; 2012 Jun; 19(6):1790-9. PubMed ID: 22203181
[TBL] [Abstract][Full Text] [Related]
40. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]